Andrew Summers Sells 35,273 Shares of Electromed, Inc. (NYSE:ELMD) Stock

Electromed, Inc. (NYSE:ELMD) Director Andrew Summers sold 35,273 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $28.83, for a total transaction of $1,016,920.59. Following the completion of the sale, the director now owns 129,190 shares of the company’s stock, valued at approximately $3,724,547.70. This trade represents a 21.45 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Andrew Summers also recently made the following trade(s):

• On Monday, February 24th, Andrew Summers sold 50,751 shares of Electromed stock. The shares were sold at an average price of $27.30, for a total value of $1,385,502.30.
• On Wednesday, December 4th, Andrew Summers sold 12,731 shares of Electromed stock. The stock was sold at an average price of $29.98, for a total value of $381,675.38.
• On Monday, December 2nd, Andrew Summers sold 17,463 shares of Electromed stock. The shares were sold at an average price of $30.09, for a total value of $525,461.67.

Electromed Trading Down 0.8 %

Electromed stock opened at $26.76 on Wednesday. The business’s 50 day simple moving average is $31.35 and its 200 day simple moving average is $25.58. Electromed, Inc. has a 12 month low of $13.74 and a 12 month high of $35.56. The company has a market cap of $228.99 million, a price-to-earnings ratio of 35.68 and a beta of 0.33.

Wall Street Analyst Weigh In

ELMD has been the topic of a number of recent analyst reports. B. Riley began coverage on Electromed in a research note on Thursday, February 20th. They set a “buy” rating and a $38.00 target price on the stock. StockNews.com lowered shares of Electromed from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 19th.

Institutional Trading of Electromed

Several hedge funds have recently made changes to their positions in ELMD. Russell Investments Group Ltd. bought a new position in shares of Electromed during the 4th quarter worth $37,000. IFP Advisors Inc purchased a new stake in Electromed during the fourth quarter valued at about $59,000. Quantbot Technologies LP bought a new position in Electromed during the fourth quarter worth about $99,000. Bank of America Corp DE raised its position in shares of Electromed by 179.2% in the fourth quarter. Bank of America Corp DE now owns 4,004 shares of the company’s stock valued at $118,000 after purchasing an additional 2,570 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Electromed in the fourth quarter valued at approximately $119,000. 40.82% of the stock is currently owned by institutional investors.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.